AI
OpenAI acquires Orchestra Bio
OpenAI News · Oct 19, 2026 · 8:00 PM ET
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Why it scores
Rules judge: AI item; Source: OpenAI News.
Builder score 33
0 to 100: how useful this is for building or owning income-producing assets, digital or physical. Not a rating of how big the news is.